Detalles de la búsqueda
1.
Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
Transfusion
; 63(2): 288-293, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36573801
2.
Migration of di(2-ethylhexyl) phthalate, diisononylcyclohexane-1,2-dicarboxylate and di(2-ethylhexyl) terephthalate from transfusion medical devices in labile blood products: A comparative study.
Vox Sang
; 118(7): 533-542, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246454
3.
Cold stored platelets - Increasing understanding and acceptance.
Transfus Apher Sci
; 62(3): 103639, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36631316
4.
Beyond COVID-19 and lessons learned in the United States.
Transfus Med
; 33(1): 6-15, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35918741
5.
Buffy coat platelets coming to America: Are we ready?
Transfusion
; 61(2): 627-633, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33174258
6.
Non-phthalate plasticizer DEHT preserves adequate blood component quality during storage in PVC blood bags.
Vox Sang
; 116(1): 60-70, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918773
7.
Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
Transfusion
; 60(11): 2655-2660, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32830340
8.
Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
Vox Sang
; 115(3): 146-151, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31930543
9.
Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
Transfusion
; 59(7): 2223-2227, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31050821
10.
Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
Transfusion
; 58(9): 2202-2207, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29732571
11.
Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
Transfusion
; 57(11): 2677-2682, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28718518
12.
Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
Transfusion
; 56(9): 2278-85, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27456861
13.
Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.
Transfus Med Hemother
; 38(1): 55-64, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21779206
14.
Plasma transfusion volume and liver transplantation safety.
Transfusion
; 53(10): 2353-4, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24099342
15.
Updates on pathogen inactivation of plasma using Theraflex methylene blue system.
Transfus Apher Sci
; 38(3): 271-80, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18487089
16.
Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.
Transfusion
; 50(2): 516-8, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20233360
17.
Tropomyosin 4 expression is enhanced in dedifferentiating smooth muscle cells in vitro and during atherogenesis.
Eur J Cell Biol
; 82(9): 473-82, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-14582535
18.
Factor VIII and fibrinogen recovery in plasma after Theraflex methylene blue-treatment: effect of plasma source and treatment time.
Blood Transfus
; 12(2): 226-31, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24931842
Resultados
1 -
18
de 18
1
Próxima >
>>